Free Trial

Cyclerion Therapeutics (CYCN) Institutional Ownership

Cyclerion Therapeutics logo
$3.18 0.00 (0.00%)
Closing price 05/22/2026 04:00 PM Eastern
Extended Trading
$3.13 -0.05 (-1.57%)
As of 05/22/2026 07:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Cyclerion Therapeutics (NASDAQ:CYCN)

Current
Institutional Ownership
Percentage
75.62%
Number of
Institutional Buyers
(last 12 months)
1
Total
Institutional Inflows
(last 12 months)
$30.57K
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$27.91K
Get CYCN Insider Trade Alerts

Want to know when executives and insiders are buying or selling Cyclerion Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

CYCN Institutional Buying and Selling by Quarter

Cyclerion Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/14/2025 Two Sigma Investments LP13,293$31K0.0%N/A0.398%
8/15/2025 Tyndall Capital Partners L P155,187$452K100.0%-5.8%4.646%
2/13/2025Renaissance Technologies LLC10,611$34K0.0%N/A0.392%
2/14/2024Tyndall Capital Partners L P164,429$551K100.0%+11.3%6.711%
11/14/2023Tyndall Capital Partners L P147,712$505K100.0%N/A6.129%
8/11/2023Artal Group S.A.138,955$572K0.0%-95.0%5.766%
5/9/2022Trustcore Financial Services LLC292,645$325K0.0%+47.7%0.674%


CYCN Institutional Ownership - Frequently Asked Questions

During the previous two years, the following institutional investors and hedge funds held shares of Cyclerion Therapeutics shares: Tyndall Capital Partners L P ($452K), and Renaissance Technologies LLC ($34K), Two Sigma Investments LP ($31K).Learn more on Cyclerion Therapeutics' institutional investors.

75.62% of Cyclerion Therapeutics' stock is owned by institutional investors. Learn more on CYCN's institutional investor holdings.

The following institutional investors have purchased Cyclerion Therapeutics' stock in the last 24 months: Two Sigma Investments LP ($13.29K), and Renaissance Technologies LLC ($10.61K).

Institutional investors have bought a total of 13,293 shares in the last 24 months. This purchase volume represents approximately $30.57K in transactions.

The following institutional investors have sold Cyclerion Therapeutics stock in the last 24 months: Tyndall Capital Partners L P ($9.59K).

Institutional investors have sold a total of 9,590 shares in the last 24 months. This volume of shares sold represents approximately $27.91K in transactions.



This page (NASDAQ:CYCN) was last updated on 5/26/2026 by MarketBeat.com Staff.
From Our Partners